ATYR PHARMA, INC. (ATYR) Operating income 2016–2025
ATYR PHARMA, INC. (ATYR) annual operating income history from SEC filings — each fiscal year as reported.
-$77.6MFY2025 · since FY2016: -$57.9M → -$77.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$77.6M | -14.3% |
| FY2024 | -$67.9M | -23.7% |
| FY2023 | -$54.9M | -18.3% |
| FY2022 | -$46.4M | -36.4% |
| FY2021 | -$34.0M | -113.8% |
| FY2020 | -$15.9M | +30.8% |
| FY2019 | -$23.0M | +30.0% |
| FY2018 | -$32.8M | +30.4% |
| FY2017 | -$47.1M | +18.6% |
| FY2016 | -$57.9M | — |
Source: SEC XBRL filings · For reference only · Not investment advice